ASIA-PACIFIC CONFERENCE: CoEHAR launches Tobacco Harm Reduction dialogue in Asia, starting with Indonesia

The leadership of CoEHAR and researchers from the Asian hub coordinated by Prof. Ronny Lesmana of the Padjadjaran University successfully concluded the first edition of the "Asia-Pacific Conference on smoking…

Continue ReadingASIA-PACIFIC CONFERENCE: CoEHAR launches Tobacco Harm Reduction dialogue in Asia, starting with Indonesia

New Respiratory Symptoms Tool Confirms: Vapers and Heated Tobacco Users Report Fewer Lung Symptoms Than Smokers

Catania, May 2, 2025 – Smokers who quit—either entirely or by switching to alternatives such as e-cigarettes or heated tobacco products—report significantly fewer respiratory symptoms compared to those who continue…

Continue ReadingNew Respiratory Symptoms Tool Confirms: Vapers and Heated Tobacco Users Report Fewer Lung Symptoms Than Smokers

Experts from 11 Countries Join Forces to Tackle Tobacco’s Hidden Impact on Dental Health

Catania, April 22 - A recent expert review published in the Journal of Dentistry highlights the compounded oral health challenges faced by smokers. Beyond the well-known risks of lung and heart diseases,…

Continue ReadingExperts from 11 Countries Join Forces to Tackle Tobacco’s Hidden Impact on Dental Health

University of Catania Hosts International Scientific Meeting on Diabetes, Personalized Medicine, and Tobacco Harm Reduction

The University of Catania is proud to announce the upcoming international scientific conference titled "TYPE 2 Diabetes in Internal Medicine Practice: Experience Sharings 1", which will take place on May 30-31, 2025,…

Continue ReadingUniversity of Catania Hosts International Scientific Meeting on Diabetes, Personalized Medicine, and Tobacco Harm Reduction

CoEHAR publishes the world’s first study assessing the impact of modified-risk products on eye health

Toxic compounds released by cigarette smoke are linked to inflammation and oxidative stress in the eye, both of which are risk factors for more severe ocular diseases. But what happens…

Continue ReadingCoEHAR publishes the world’s first study assessing the impact of modified-risk products on eye health